risks of compounded semaglutide is not the same as FDA-approved. The FDA has documented dosing errors and hospitalizations linked to these products. Dr. Jen Ashton breaks down the risks. Always consult your physician before E-sellers of compounded weight-loss drugs

Important Limitations Despite these benefits, GLP-1 medications are not fertility treatments

Glucagon-like peptide-1 (GLP-1) receptor agonists represent a class of medications increasingly prescribed for type 2 diabetes management and, more recently, for weight management in adults with obesity

this is a class-level precaution rather than an established risk specific to retatrutide

We have to be careful that consensus is not just groupthink, Brecka says

Additionally, significant associations of GLP-1 were found with markers of inflammation, including IL-6 and C-reactive protein (CRP) in critically ill patients, and endotoxin, IL-1, and IL-6 were sufficient to induce GLP-1 secretion in mice (61)

doi: 10.1038/s42003-021-01706-0